MACM

March Altus Capital Management Portfolio holdings

AUM $16M
1-Year Est. Return 18.92%
This Quarter Est. Return
1 Year Est. Return
+18.92%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$12.9M
AUM Growth
+$3.27M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
10
New
Increased
Reduced
Closed

Top Buys

1
+$1.99M
2
+$1.58M
3
+$963K
4
EW icon
Edwards Lifesciences
EW
+$116K

Top Sells

1
+$826K
2
+$680K
3
+$583K

Sector Composition

1 Healthcare 89.33%
2 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACAD icon
1
Acadia Pharmaceuticals
ACAD
$3.84B
$2.69M 20.75%
82,723
+61,171
LLY icon
2
Eli Lilly
LLY
$757B
$2.11M 16.32%
26,810
EW icon
3
Edwards Lifesciences
EW
$49B
$1.86M 14.35%
55,833
+3,504
JNJ icon
4
Johnson & Johnson
JNJ
$455B
$1.58M 12.19%
+13,000
ALGN icon
5
Align Technology
ALGN
$10B
$1.4M 10.78%
17,319
+11,953
PETX
6
DELISTED
Aratana Therapeutics, Inc.
PETX
$1.38M 10.67%
218,515
ALXN
7
DELISTED
Alexion Pharmaceuticals
ALXN
$1M 7.76%
8,599
DXCM icon
8
DexCom
DXCM
$26.7B
$928K 7.17%
46,800
-29,384
REGN icon
9
Regeneron Pharmaceuticals
REGN
$68.7B
– –
-2,291
ATHN
10
DELISTED
Athenahealth, Inc.
ATHN
– –
-4,900